Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Novo Nordisk A S filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Feb 4, 2026 | 20-F | – | Dec 31, 2025 | SEC | Index |
| Feb 5, 2025 | 20-F | – | Dec 31, 2024 | SEC | Index |
| Jan 31, 2024 | 20-F | – | Dec 31, 2023 | SEC | Index |
| Feb 1, 2023 | 20-F | – | Dec 31, 2022 | SEC | Index |
| Feb 2, 2022 | 20-F | – | Dec 31, 2021 | SEC | Index |
| Feb 3, 2021 | 20-F | – | Dec 31, 2020 | SEC | Index |
| Feb 5, 2020 | 20-F | – | Dec 31, 2019 | SEC | Index |
| Feb 4, 2019 | 20-F | – | Dec 31, 2018 | SEC | Index |
| Feb 8, 2018 | 20-F | – | Dec 31, 2017 | SEC | Index |
| Feb 9, 2017 | 20-F | – | Dec 31, 2016 | SEC | Index |
| Feb 10, 2016 | 20-F | – | Dec 31, 2015 | SEC | Index |
| Feb 5, 2015 | 20-F | – | Feb 10, 2014 | SEC | Index |
| Feb 5, 2014 | 20-F | – | Dec 31, 2013 | SEC | Index |
| Jun 28, 2013 | 20-F/A | – | Dec 31, 2012 | SEC | Index |
| Feb 6, 2013 | 20-F | – | Dec 31, 2012 | SEC | Index |
| Feb 8, 2012 | 20-F/A | – | Dec 31, 2011 | SEC | Index |
| Feb 6, 2012 | 20-F | – | Feb 6, 2012 | SEC | Index |
| Feb 14, 2011 | 20-F | – | Dec 31, 2010 | SEC | Index |
| Feb 11, 2010 | 20-F | – | Dec 31, 2009 | SEC | Index |
| Feb 9, 2009 | 20-F | – | Dec 31, 2008 | SEC | Index |